Altre lingue Twist Bioscience Corporation

Azioni

TWST

US90184D1000

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:03 31/05/2024			Variaz. 5gg	Var. 1 gen.
41,88 ^USD	+2,57%		-0,83%	+13,62%

22/05	Oxford Nanopore Technologies collabora con Twist Bioscience per lanciare il Programma Beta di Farmacogenomica e far progredire la Medicina Personalizzata	CI
13/05	Twist Bioscience lancia i frammenti genici multiplexati per consentire applicazioni di screening ad alta produttività	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Oxford Nanopore Technologies Collaborates with Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine	22/05
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-Throughput Screening Applications	13/05
Sector Update: Health Care Stocks Mixed Late Afternoon	03/05
Sector Update: Health Care Stocks Mixed in Afternoon Trading	03/05
Twist Bioscience Shares Jump After Fiscal Q2 Beat, Fiscal 2024 Revenue Guidance Raised	03/05
Transcript : Twist Bioscience Corporation, Q2 2024 Earnings Call, May 02, 2024	02/05
Twist Bioscience Corporation Revises Earnings Guidance for the Fiscal Year 2024	02/05
Twist Bioscience Corporation Provides Earnings Guidance for the Third Quarter and Fourth Quarter of Fiscal Year 2024	02/05
Twist Bioscience Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	02/05
Twist Bioscience Corporation Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations	28/03
Transcript : Twist Bioscience Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 07:30 AM	12/03
Twist Bioscience Corporation Launches IVDR-Compliant Precision Dx Products for Whole Exome Sequencing	05/03
Twist Bioscience Announces Partnership With Element Biosciences, Launches Liquid Biopsy Kit	06/02
Twist Bioscience Corporation and Element Biosciences, Inc. Announce Collaboration to Develop Twist for Element, Exome 2.0 Plus Comprehensive Exome Spike-In Workflow for Element?s AVITI System	06/02
Twist Bioscience Corporation Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications	06/02
TWIST BIOSCIENCE CORPORATION : Scotiabank toujours positif	05/02
Twist Bioscience Corporation Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT	05/02
Sector Update: Health Care Stocks Steady Premarket Friday	02/02
Twist Bioscience's Fiscal Q1 Net Loss Widens, Revenue Rises; Fiscal 2024 Revenue Guidance Lifted	02/02
Transcript : Twist Bioscience Corporation, Q1 2024 Earnings Call, Feb 02, 2024	02/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Twist Bioscience Corporation

Azioni

TWST

US90184D1000

Altre lingue

Filtri